PADI4 and autoimmune disease: Additionally, PAD4 inhibitor Cl-amidine or BB-Cl-amidine shows a good therapeutic effect on heart failure-associated autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, MPO-ANCA-associated vasculitis, and Behçet's disease [259–263].